• Precision Medicine AI Agent Platform
          • Precision Medicine AI Agent Platform
          • Security & Compliance
        • Solutions
          • Overview
          • Agent Intelligence (AI)
          • Sample Intelligence (SI)
          • Biomarker Intelligence (BI)
        • Resources
          • News & Insights
          • Webinars & Events
          • FAQs
          • Case Studies
          • Literature
        • About Us
          • Overview
          • Leadership
          • Careers
          • Contact Us
  • Search
  • Menu Menu
Precision Medicine AI Agent Platform Solutions
Log in Book A Demo

QuartzBio Helps Keep Oncology Trial on Track at a Clinical-Stage Biotech 

A clinical-stage biopharmaceutical company has been developing novel therapeutics that selectively modulate gene expression to address unmet medical needs in cancer patients.  

To keep their phase I study of an epigenetic modulator on track, the program’s translational research team needed to be able to monitor clinical outcomes with respect to patients and with respect to biomarker-defined subgroups. 

To achieve this goal, the team needed to manage multiple data streams: 

  • Central lab sample inventory 
  • EDC/Clinical data 
  • Assay results data from multiple specialty labs, including IHC, flow cytometry, PK, and gene expression 

Biomarker Data Management (BDM) & virtual Sample Inventory Management (vSIM) 

In weeks, QuartzBio deployed its vSIM and BDM solutions to the clinical trial in progress, enabling the translational research team to: 

  • Gain centralized visibility into status of samples as they move from sites to central and specialty labs 
  • Revealed insights on actual samples collected vs. expected samples collected 
  • Generate hypotheses based on biomarker assay results linked to patient clinical data and dosage information 
  • Eliminate time-consuming and manual data cleaning and cross-referencing processes
Explore QuartzBio Solutions & Use Cases
https://www.quartz.bio/wp-content/uploads/2024/08/placeholder-image.png 320 480 QuartzBio Team https://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svg QuartzBio Team2022-03-15 18:04:302025-03-24 15:16:33Biomarker-guided oncology trial
https://www.quartz.bio/wp-content/uploads/2024/08/Figure-1-gene-expression-v-response-status-heatmap.png 945 2000 QuartzBio Team https://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svg QuartzBio Team2022-03-15 18:04:212025-03-24 15:16:39Drug response signatures

QuartzBio’s approach to biomarker data management can be seen in the context of a phase 2/3 dose evaluation and expansion oncology study with 5 assays run at 4 different labs. Using QuartzBio’s technology-driven solution, the sponsor could:

  • Pull together and visualize PK, cytokine, and flow cytometry data to inform optimal dosing
  • Integrate mutation, IHC, and cytokine data to develop a multimarker signature to stratify patients

The cross-functional QuartzBio team—including data scientists, biomarker data management programmers, and data managers—delivered a centralized data hub for biomarker data transfer, integration, and collaboration, as well as interactive reports and support for ongoing trial activities.

The client found that our approach transformed their ability to reach key clinical trial objectives.

Explore Biomarker Data Management

https://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svg 0 0 QuartzBio Team https://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svg QuartzBio Team2022-03-15 18:04:002025-03-24 15:16:46Biomarker Data Management in phase 2/3
Page 2 of 212

Search

QuartzBio Logo_The Precision Medicine Intelligence Company _white
  • Precision Medicine AI Agent Platform
  • Solutions
  • Log In
  • Book a Demo
  • Resources
  • About Us

Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments. Precision for Medicine is part of Precision Medicine Group, with 3,000 employees in 40 locations.

QUARTZBIO® and the PRECISION QUARTZBIO® logo are registered trademarks of Precision Medicine Group, LLC in the United States and/or other jurisdictions. All rights reserved.

© 2024. All rights reserved.
Precision Medicine Group, LLC.
Privacy Policy | GDPR

Web Design and Development by RainCastle Communications.

  • Precision Medicine AI Agent Platform
    • Precision Medicine AI Agent Platform
    • Security & Compliance
    • Back
  • Solutions
    • Overview
    • Agent Intelligence (AI)
    • Sample Intelligence (SI)
    • Biomarker Intelligence (BI)
    • Back
  • Resources
    • News & Insights
    • Webinars & Events
    • FAQs
    • Case Studies
    • Product Literature
    • Back
  • About Us
    • Overview
    • Leadership
    • Careers
    • Contact Us
    • Back
  • Login
  • Book a Demo

Contact App Support



Request Documentation